P30 HPV Supplement Grants Awarded to CPCRN Investigators at the University of Iowa and Oregon Health and Science University

University of Iowa and the The Oregon Health and Science University Knight Cancer Institute have both been awarded P30 HPV Supplement Grants for NCI-Designated Cancer Centers.

Iowa’s year-long project will investigate HPV vaccination disparities in rural Iowa counties. They’ll conduct an environmental scan looking at community, clinic and organizational factors related to uptake of the HPV vaccine in rural areas. Rural counties with large discrepancies between the rates of HPV vaccination and rates of adolescents who are up-to-date on other vaccinations (Hepatitis B, Meningococcal, MMR, Tdap/Td, and Varicella) will be a priority in the scan. Research team members include CPCRN members Natoshia Askelson and Laura Seegmiller.

OHSU’s catchment area is inclusive of the state of Oregon; a largely rural state with approximately 36% of residents living in areas designated as rural or frontier. They’ll conduct environmental scans – collecting data from each level on the socioecological model – in seven rural counties that reflect dyads or triads of geographically similar counties and which have very divergent HPV immunization coverage. By scanning areas of both highest and lowest uptake, they’ll identify both barriers and facilitators to full vaccination among adolescents and ideally approaches to improvement that may be most easily shared across rural regions. Research team members include CPCRN members Jackilen Shannon, Paige Farris and Advisory Team members Michelle Berlin and Robin Vanderpool.